The study was conducted in partnership with Abera Bioscience, a platform and vaccine developer with over 30 years of research in the medical, molecular and microbiological fields. Both formulations tested induced strong systemic antibody response in serum (IgG) as well as locally in the...
Read More Details
Finally We wish PressBee provided you with enough information of ( Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology )
Also on site :
- ThreatHunter.ai Eliminates MFA Attacks with MILBERT, the First Agentic AI Built to Kill Session Hijacks in Real Time
- DIGITAL HEALTH LEADER JMIR PUBLICATIONS ANNOUNCES ITS 2025 IMPACT FACTOR RESULTS
- Landmark Report from Dole and Kennedy Institutes Identifies Need for Greater Funding of Election Administrators